clinically based product applications in the
Cosmetic and Supplement markets.
clinically based product applications
Cosmetics
According to the new Modernization of Cosmetics Regulation Act in the United States (MoCRA), cosmetic manufacturers will be required to register their facility, update label requirements, and follow GMP standards by 2025. Since our facility already follows GMP, Kazmira is uniquely positioned to be in compliance with these new regulations. In addition, our dedication to ingredient safety and efficacy has led us to clinical research including formulation and human testing (in-vitro and in-vivo). Please reach out to learn more about exciting discoveries we have made using Imperial® Oil and Silver Plume® for efficacy in cosmetics and opportunities for brand line extensions.
CBD Supplements
Self care applications continue to be the largest market opportunity for CBD, but regulatory inaction has stunted growth. There are major issues in the market when it comes to safety, efficacy, and transparent labeling of these products. As the industry continues to evolve, it is abundantly clear that safety is the number one concern for government regulators and consumers alike. Kazmira is dedicated to consumer safety, which is why we put our products through rigorous internal and external analysis to ensure that consumers are getting the highest quality and safest product possible. Our focused effort towards in-vitro and in-vivo ingredient testing for toxicity, safety, and efficacy will continue to help consumers make informed choices about the products they are purchasing.
ABOUT
NEWSLETTER
Premier cannabinoid education for brand owners and industry professionals.
Food and Drug Administration (FDA) Disclaimer
These statements have not been evaluated by the FDA. These products are not intended to diagnose, treat, cure or prevent any disease.
Terms & Conditions | Privacy Policy | Shipping & Return Policy | FDA Disclaimer